Because of the recent concern in the United States around the rise of resistant pathogens, intravenous fosfomycin has gained renewed interest because of its activity and demonstrated synergy with other classes of antibiotics.
Amira Bhalodi, PharmD
Advertisement
Articles by Amira Bhalodi, PharmD
Advertisement
Latest Updated Articles
Intravenous Fosfomycin In Development for United StatesPublished: October 25th 2018 | Updated:
Advertisement
Advertisement
Trending on Contagion Live
1
Developing a COVID-19 Vaccine Alternative
2
Practically Expanding AI's role in Infectious Diseases
3
Real-World Data Reinforce Effectiveness and Safety of Fecal Microbiota Therapy for Preventing Recurrent C difficile
4
Maternal and Infant RSV Immunization Safe, Boosts Antibody Levels Regardless of Sequence
5
